Cancer and Metastasis Reviews

, Volume 14, Issue 4, pp 279–301 | Cite as

Steps in tumor metastasis: new concepts from intravital videomicroscopy

  • Ann F. Chambers
  • Ian C. MacDonald
  • Eric E. Schmidt
  • Sahadia Koop
  • Vincent L. Morris
  • Rama Khokha
  • Alan C. Groom
Article

Summary

Metastases are responsible for the majority of failures in cancer treatment. Clarifying steps in metastasis and their molecular mechanisms will be important for the development of anti-metastasis therapeutic strategies. Considerable progress has been made in identifying molecules involved in metastasis. However, because of the nature of assays that have been available, conclusions about steps in metastasis and their molecular bases have been drawn primarily from inference. In order to complete the picture of how metastases form, a technique is needed to directly watch the processin vivo as it occurs over time. We have developed an intravital videomicroscopy (IVVM) procedure to make such observations possible. Results from IVVM are providing us with new conceptual understanding of the metastatic process, as well as the nature and timing of the contributions of molecules implicated in metastasis (e.g. adhesion molecules and proteinases). Our findings suggest that early steps in metastasis, including hemodynamic destruction and extravasation, may contribute less to metastatic inefficiency than previously believed. Instead, our results suggest that the control of post-extravasation growth of individual cancer cells is a significant contributor to metastatic inefficiency. Thus, this stage may be an appropriate target for design of novel strategies to prevent metastases.

Key words

metastasis videomicroscopy extravasation in vivo assays metastatic inefficiency anti-metastasis therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liotta LA, Stetler-Stevenson WG: Principles of molecular cell biology of cancer: cancer metastasis. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, 4th Ed., J.B. Lippencott Co., Philadelphia, 1993, pp 134–149Google Scholar
  2. 2.
    Butler TP, Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35: 512–516, 1975Google Scholar
  3. 3.
    Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997–1004, 1974Google Scholar
  4. 4.
    Weiss L: Random and nonrandom processes in metastasis, and metastatic inefficiency. Invasion metastasis 3: 193–207, 1983Google Scholar
  5. 5.
    Weiss L: Metastatic inefficiency. Adv Cancer Res 54: 159–211, 1990Google Scholar
  6. 6.
    Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336, 1991Google Scholar
  7. 7.
    Stetler-Stevenson WG, Liotta LA, Kleiner DJ, Jr: Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434–1441, 1993Google Scholar
  8. 8.
    Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161–195, 1993Google Scholar
  9. 9.
    Nicolson GL, Barnes G, Jr. Malignant cell properties important in the organ preference of metastasis. In: Pretlow TG, Pretlow TP (eds) Biochemical and Molecular Aspects of Selected Cancers, Academic Press, 1994, pp 467–494Google Scholar
  10. 10.
    Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59: 329–341, 1993Google Scholar
  11. 11.
    Sloane BF, Moin K, Lah TT: Regulation of lysosomal endopeptidases in malignant neoplasia. In: Pretlow TG, Pretlow TP (eds) Biochemical and Molecular Aspects of Selected Cancers, Academic Press, 1994, pp 411–466Google Scholar
  12. 12.
    Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25, 1982Google Scholar
  13. 13.
    Tedder TF, Steeber DA, Chen A, Engel P: The selectins: vascular adhesion molecules. FASEB J 9: 866–873, 1995Google Scholar
  14. 14.
    Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 2068–2101, 1994Google Scholar
  15. 15.
    Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314, 1994Google Scholar
  16. 16.
    Juliano RL, Varner JA: Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5: 812–818, 1993Google Scholar
  17. 17.
    Dedhar S: Integrins and tumor invasion. Bioeassays 12: 583–590, 1990Google Scholar
  18. 18.
    Lafrenie RM, Buchanan MR, Orr FW: Adhesion molecules and their role in cancer metastasis. Cell Biophys 23: 3–89, 1993Google Scholar
  19. 19.
    Zetter BR: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219–229, 1993Google Scholar
  20. 20.
    Morris VL, MacDonald IC, Koop S, Schmidt EE, Chambers AF, Groom AC: Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis 11: 377–390, 1993Google Scholar
  21. 21.
    Morris VL, Koop S, MacDonald IC, Schmidt EE, Grattan M, Percy D, Chambers AF, Groom AC: Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis 12: 357–367, 1994Google Scholar
  22. 22.
    Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, Khokha R, Chambers AF, Groom AC: Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res 55: 2520–2523, 1995Google Scholar
  23. 23.
    MacDonald IC, Schmidt EE, Morris VL, Chambers AF, Groom AC: Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. Microvasc Res 44: 185–199, 1992Google Scholar
  24. 24.
    Weiss L: The biomechanics of cancer cell traffic, arrest, and intravascular destruction. In: Orr FW, Buchanan MR, Weiss L (eds) Microcirculation in Cancer Metastasis, CRC Press, Inc. Boca Raton, 1991, pp 131–144Google Scholar
  25. 25.
    Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV: Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. Lab Invest 53: 470–478, 1985Google Scholar
  26. 26.
    Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV: Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48: 4065–4072, 1988Google Scholar
  27. 27.
    Weiss L, Schmid-Schönbein GW: Biomechanical interactions of cancer cells with the microvasculature during metastasis. Cell Biophys 14: 187–215, 1989Google Scholar
  28. 28.
    Morris VL, Schmidt EE, Koop S, MacDonald IC, Grattan M, Khokha R, McLane MA, Niewiarowski S, Chambers AF, Groom AC: Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp Cell Res 219: 571–578, 1995Google Scholar
  29. 29.
    Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC: Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791–4797, 1994Google Scholar
  30. 30.
    Chew EC, Josephson RL, Wallace AC: Morphologic aspects of the arrest of circulating cancer cells. In: Weiss L (ed) Fundamental Aspects of Metastasis, North-Holland Publishing Company, 1976, pp 121–150Google Scholar
  31. 31.
    Dingeman KP, Roos E: Ultrastructural aspects of the invasion of liver by cancer cells (II). In: Weiss L, Gilbert HA (eds) Liver Metastasis, G.K. Hall Medical Publishers, Boston, 1982, pp 51–76Google Scholar
  32. 32.
    Morris VL, Tuck AB, Wilson SM, Percy D, Chambers AF: Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin Exp Metastasis 11: 103–112, 1993Google Scholar
  33. 33.
    Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cellsin vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299–304, 1994Google Scholar
  34. 34.
    Chambers AF, Schmidt EE, MacDonald IC, Morris VL, Groom AC: Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. J Natl Cancer Inst 84: 797–803, 1992Google Scholar
  35. 35.
    Ausprunk D, Dethlefson S, Higgins E: Distribution of fibronectin, laminin and type IV collagen during development of blood vessels in the chick chorioallantoic membrane. In: Feinberg R, Sherer G, Auerbach R (eds) The Development of the Vascular System, Karger S, Basel, 1991, pp 93–108Google Scholar
  36. 36.
    Fidler IJ, Gersten DM, Budmen MB: Characterizationin vivo andin vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res 36: 3160–3165, 1976Google Scholar
  37. 37.
    Norton L: Introduction to clinical aspects of preneoplasia: a mathematical relationship between stromal paracrine autonomy and population size. In: Marks PA, Türler H, Weil R (eds) Precancerous Lesions: A Multidisciplinary Approach, Ares-Serono Symposia, Rome, 1993, pp 269–275Google Scholar
  38. 38.
    Nicolson GL: Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204: 171–180, 1993Google Scholar
  39. 39.
    Nicolson GL: Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 12: 325–343, 1993Google Scholar
  40. 40.
    Mendelsohn J, Lippman ME: Principles of molecular cell biology of cancer: growth factors. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, 4th Ed., J.B. Lippincott Co Philadelphia, 1993, pp 114–133Google Scholar
  41. 41.
    Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931–10934, 1992Google Scholar
  42. 42.
    Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1: 149–153, 1995Google Scholar
  43. 43.
    Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856–1862, 1995Google Scholar
  44. 44.
    Schipper H, Goh CR, Wang TL: Rethinking cancer: should we control rather than kill? Part 1. Can J Oncol 3: 207–216, 1993Google Scholar
  45. 45.
    Schipper H, Goh CR, Wang TL: Rethinking cancer: should we control rather than kill? Part 2. Can J Oncol 3: 220–224, 1993Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Ann F. Chambers
    • 1
  • Ian C. MacDonald
    • 2
  • Eric E. Schmidt
    • 2
  • Sahadia Koop
    • 2
  • Vincent L. Morris
    • 1
  • Rama Khokha
    • 1
    • 4
    • 6
  • Alan C. Groom
    • 2
    • 5
  1. 1.Departments of OncologyUniversity of Western OntarioLondon, OntarioCanada
  2. 2.Departments of Medical BiophysicsUniversity of Western OntarioLondon, OntarioCanada
  3. 3.Departments of Microbiology and ImmunologyUniversity of Western OntarioLondon, OntarioCanada
  4. 4.Departments of BiochemistryUniversity of Western OntarioLondon, OntarioCanada
  5. 5.John P. Robarts Research InstituteLondon, OntarioCanada
  6. 6.London Regional Cancer CentreLondon, OntarioCanada

Personalised recommendations